About Lightstone Ventures
Lightstone Ventures is a venture capital firm founded in 2012. It is primarily based out of Menlo Park, United States. As of Mar 2025, Lightstone Ventures is an active investor, having invested in 89 companies, with 1 new investment in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $57.5M Series D round of Allay Therapeutics along with New Enterprise Associates. This round also saw participation from EDBI and other investors.
Overall, Lightstone Ventures portfolio has seen 2 unicorns, 10 IPOs and 31 acquisitions including key companies like Porter, Vivriti Capital and ALX Oncology. A lot of funds co-invest with Lightstone Ventures, with names like New Enterprise Associates sharing a substantial percentage of its portfolio.
Lightstone Ventures has team of 20 people including 8 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Acquisitions
Vigil, Gynesonics &
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Lightstone Ventures' List of Top Investments
Lightstone Ventures has a portfolio of 89 companies, including 2 unicorns. Their most notable investments are in Nimbus Therapeutics and Nimbus Therapeutics.Their portfolio spans across United States, India, IrelandÌý²¹²Ô»å 4 more locations. They have invested in Life Sciences, High Tech, HealthTechÌý²¹²Ô»å 9 other sectors, across stages such as Series A, Series B Ìý²¹²Ô»å 3 more. Here is the list of top investments by Lightstone Ventures:
1. Porter
App-based platform offering on-demand trucking and relocation services. The platform offers intracity and intercity delivery services through two-wheeler and trucks. It provides a mobile application that allows users to provide the pickup and delivery location to deliver the goods. The platform enables users to select the delivery vehicle type and type of goods to be delivered. It allows users to track the delivery. The application is available on Apple Store and Google Play Store.
Key facts about Porter
- Founded Year: 2014
- Location: Bengaluru (India)
- Annual Revenue: ₹2,770Cr as on Mar 31, 2024
- Valuation: $1.2B as on May 08, 2025
- Stage: Series F
- Total Funding till date: $151M
- Employee Count: 1,940 as on Apr 30, 2025
- Investors: Wellington, Lightstone Ventures and 59 Others
- Latest Funding Round: Series F, May 08, 2025
- Highlight: Editors' Pick
Developer of a debt financing platform for corporates, SMEs, and individuals. It offers users a range of financial products including loans, receivables finance, working capital, structured debt, and capital market instruments. It also provides webinars and insights to assist in making lending decisions.
Key facts about Vivriti Capital
- Founded Year: 2017
- Location: Chennai (India)
- Annual Revenue: ₹1,110Cr as on Mar 31, 2024
- Valuation: ₹14,100Cr as on Nov 03, 2023
- Stage: Series D
- Total Funding till date: $205M
- Employee Count: 695 as on Jan 31, 2025
- Investors: Lightstone Ventures, TVS Capital Funds and 20 Others
- Latest Funding Round: Conventional Debt, Sep 30, 2024, $25M
- Highlight: Editors' Pick
Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases. The lead candidate targets ACC for Nonalcoholic Steatohepatitis (NASH). The other drug candidate is an IRAK4 inhibitor used to target Tyk2 and KRas that mediates immune signaling.
Key facts about Nimbus Therapeutics
- Founded Year: 2009
- Location: Cambridge (United States)
- Stage: Series F
- Total Funding till date: $637M
- Employee Count: 81 as on Dec 31, 2022
- Investors: SR One, Citadel and 20 Others
- Latest Funding Round: Series F, Sep 06, 2023, $210M
- Highlight: Editors' Pick
_1549346058109.png?format=webp&height=120&width=120){kind=logo}
4. ALX Oncology
Developer of immuno-oncology therapies for cancer treatment. The lead product candidate ALX148 is a checkpoint inhibitor that comprises an affinity CD47 binding domain of SIRPα linked to an inactive Fc region of a human immunoglobulin. It binds CD47 and inhibits the CD47-SIRPα signaling pathway.
Key facts about ALX Oncology
- Founded Year: 2015
- Location: Burlingame (United States)
- Stage: Public
- Total Funding till date: $123M
- Employee Count: 59 as on Dec 31, 2022
- Investors: Foresite Capital, Vivo Capital and 9 Others
- Latest Funding Round: Series C, Feb 12, 2020, $105M
- Highlight: Public
5.
Key facts about Vapotherm
- Founded Year: 1999
- Location: Exeter (United States)
- Annual Revenue: $68.7M as on Dec 31, 2023
- Stage: Public
- Total Funding till date: $170M
- Employee Count: 353 as on Dec 31, 2022
- Investors: Adage Capital Management, Gilde Healthcare and
- Latest Funding Round: Post IPO, Feb 10, 2023
- Highlight: Public
Lightstone Ventures' Year-on-Year Investment Trends
Lightstone Ventures has invested in 89 companies over the last 11 years, with an average of 3 new investments annually in the last 10 years. In 2024, it made 4 investments, while as of Mar 2025, it has made 3 investments in this year. Its most recent first time investment was in Allay Therapeutics and most recent follow-on round was in Atsena Therapeutics.
Year | No. of Investments | ||
|---|---|---|---|
1stÌý¸é´Ç³Ü²Ô»å | Follow-on | Total | |
2025 (YTD) | 1 | 2 | 3 |
2024 | 2 | 2 | 4 |
2023 | 2 | 5 | 7 |
2022 | 2 | 2 | 4 |
2021 | 2 | 1 | 3 |
2020 | 8 | 4 | 12 |
2019 | 3 | 2 | 5 |
2018 | 3 | 3 | 6 |
2017 | 2 | 2 | 4 |
2016 | 4 | 2 | 6 |
Get Lightstone Ventures' portfolio delivered to your inbox!
Lightstone Ventures' Investments by Stage
Lightstone Ventures has made 16 investments in Series A stage with an average round size of $46.1M, 11 investments in Series B stage with an average round size of $40.1M, 4 investments in Series C stage with an average round size of $85M, 2 investments in Series D stage with an average round size of $38M and 2 investments in Series E stage with an average round size of $68.5M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
|---|---|
Series A | 16 |
Series B | 11 |
Series C | 4 |
Series D | 2 |
Series E | 2 |
Lightstone Ventures' Investments by Sector
Lightstone Ventures has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Internet of Things - Industry Applications and Consumer. Notably, it has invested in 74 Tech companies, 68 Enterprise (B2B) companies, 16 Tech hardware companies and at least 6 companies focusing on Consumer (B2C).
Note: We have considered here, only first round of investments
Sector | No. of Investments |
|---|---|
Life Sciences | 31 |
High Tech | 8 |
HealthTech | 6 |
Internet of Things - Industry Applications | 4 |
Consumer | 3 |
Others | 12 |
Lightstone Ventures' Investments by Geography
Lightstone Ventures has made most investments in United States (24), followed by India where it has made 3 investments.
Note: We have considered here, only first round of investments
Country | No. of Investments |
|---|---|
United States | 24 |
India | 3 |
United Kingdom | 3 |
Ireland | 2 |
France | 1 |
Others | 2 |
Lightstone Ventures' recent investments
Here are the most recent investments by Lightstone Ventures:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 27, 2025 | United States | Series C | $150M | ||
Jan 24, 2025 | United States | Series D | $57.5M | [+9] | |
Jan 07, 2025 | Ireland | Series D | $120M | Polaris Partners [+11] | |
Dec 09, 2024 | United States | Series D | $50M | Vertex Growth [+11] | |
Jun 09, 2024 | United Kingdom | Series A | $100M |
Get the detailed list of all investments by Lightstone Ventures. Download now!Unicorns in Lightstone Ventures' Portfolio
Here is a list of unicorns in Lightstone Ventures' portfolio:
ÃØÃÜÑо¿Ëù Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
73 | App-based platform offering on-demand trucking and relocation services | 2014 | Bengaluru | Series F | vutczwv | ||
73 | Developer of a debt financing platform for corporates, SMEs, and individuals | 2017 | Chennai | Series D | ugcurpt |
IPOs and Publicly Listed companies in Lightstone Ventures' Portfolio
Here are Lightstone Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 18, 2021 | Mar 08, 2018 | Series B | $29M | |
Jul 17, 2020 | Feb 12, 2020 | Series C | $105M | |
Nov 14, 2018 | - | - | - | |
Jan 30, 2015 | Sep 08, 2014 | Series B | $40M | |
Jul 02, 2014 | - | - | - |
_1549346058109.png?height=40&width=40){kind=logo}
Acquired companies in Lightstone Ventures' Portfolio
Here are Lightstone Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 21, 2025 | Aug 18, 2021 | Series B | $90M | |
Oct 14, 2024 | - | - | - | |
Sep 19, 2023 | Jun 21, 2018 | Series E | $58M | |
Sep 27, 2021 | - | - | - | |
Mar 04, 2021 | - | - | - |
Team profile of Lightstone Ventures
Lightstone Ventures has a team of 20 membersÌýincluding 8 Partners, 1 Venture Partner and 3 PrincipalsÌýlocated in United States and Ireland. Lightstone Ventures' team does not sit on the board of any company as of now.Here is a list of top team members in Lightstone Ventures:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | Menlo Park | - | ||
Partner | Boston | - | , | |
Partner | Palo Alto | - | ||
Partner | Dublin | - | ||
Partner | Menlo Park | - | ||
Partner | Redwood City | - | ||
Partner | Boston | - | ||
Partner | Boston | - | - | |
Venture Partner | Minneapolis | - | ||
Principal | Boston | - | - | |
Principal | Boston | - |
Get the full list of Lightstone Ventures' team & partners for free. Download now!Co-investors of Lightstone Ventures
Over the past 11 years, 370 investors have co-invested in Lightstone Ventures's portfolio companies.
- Invested before Lightstone Ventures:ÌýNew Enterprise Associates, Hatteras Venture Partners and 80 others have invested in rounds before Lightstone Ventures. There are 4 companies where New Enterprise Associates has invested before Lightstone Ventures and 3 companies where Hatteras Venture Partners has invested before Lightstone Ventures.
- Top Co-investors of Lightstone Ventures:Ìý94 investors entered a company along with Lightstone Ventures. These include investors like New Enterprise Associates (4 companies).
- Invested after Lightstone Ventures:ÌýA total of 194 investors have invested in Lightstone Ventures's portfolio after their investments. Top Investors include Google Ventures (3 companies), RA Capital Management (3 companies) and Wellington (2 companies).
Get full list of Lightstone Ventures' co-investors delivered to your inbox!
Recent News related to Lightstone Ventures
•
•
•
FinSMEs•Apr 04, 2025•Atsena Therapeutics, Bain Capital Life Sciences, Wellington, Lightstone Ventures and 6 others
•
Pharmaceutical Technology•Apr 03, 2025•Atsena Therapeutics, Bain Capital Life Sciences, Wellington, Lightstone Ventures and 3 others
•
The Joplin Globe•Jan 07, 2025•FIRE1, Polaris Partners, Elevage Medical Technologies, Sands Capital and 10 others
•
HIT Consultant•Dec 09, 2024•Cala Health, Vertex Growth, Nexus NeuroTech Ventures, Johnson & Johnson and 13 others
•
Medical Product Outsourcing•Aug 05, 2024•Amber Therapeutics, New Enterprise Associates, F-Prime Capital, Lightstone Ventures and 3 others
•
The Business Magazine•Jul 22, 2024•Amber Therapeutics, New Enterprise Associates, F-Prime Capital, Lightstone Ventures and 3 others
•
QuiBrescia•Jun 14, 2024•Amber Therapeutics, New Enterprise Associates, F-Prime Capital, Lightstone Ventures and 3 others
•
MassDevice•Jun 10, 2024•Amber Therapeutics, New Enterprise Associates, F-Prime Capital, Lightstone Ventures and 3 others
